Developments in health and pharmaceutical science and technology are advancing rapidly. Several methods for diagnosing disease causes and pathogenesis are now understood at the molecular and genetic levels. Sophisticated diagnostic tools can accurately determine disease differentiation and severity, leading to different drug selections for conditions previously thought to be identical due to similar phenotypic signs. This progress has led to the rapid development of drugs with specific therapeutic targets, while also increasing the complexity of drug-related issues - including drug selection that demands high safety, efficacy, and pharmacoeconomic cost considerations.

Therapeutic outcomes are no longer measured solely by pharmacological effects and clinical or laboratory signs, but also by a patient's holistic aspects: quality of life, morbidity, and mortality. Furthermore, increasing patient awareness regarding legal rights and the entitlement to safe, effective therapy drives the demand for high-quality professionalism. True professionalism requires continuous updates to knowledge and practical experience among healthcare teams, including pharmacists. The clinical medical field has long developed its professionalism, evolving from general practice to medical specialties and sub-specialties.

Given hospital accreditation requirements that mandate clinical pharmacy services, the demand for Master of Clinical Pharmacy graduates - both now and in the future - is essential.

Based on these considerations, the Faculty of Pharmacy at Universitas Airlangga relevantly established the Professional Master's Program in Clinical Pharmacy, awarding the degree Master of Clinical Pharmacy (M.Farm.Klin.).

Vision

"To become an innovative Master of Clinical Pharmacy Study Program, leading at national and international levels, a pioneer in the development and application of clinical pharmacy science, and producing graduates with superior competence in pharmaceutical care based on religious morals."

Mission

1. To conduct an innovative, high-quality, and superior Master of Clinical Pharmacy program that firmly adheres to professional ethics and religious morals.
2. To develop clinical research using biomedical-pharmaceutical and clinical pharmacy concepts to support clinical pharmacy practice.
3. To carry out community service programs in the pharmaceutical field as a social responsibility for empowerment, health improvement, and enhancing the public's quality of life.
4. To establish collaborations with various parties in education, research, and community service at national and international levels effectively, efficiently, and sustainably for the development and continuity of the Master of Clinical Pharmacy program.

Objectives

1. 1 To produce graduates who are innovative and adaptive to changes and developments in clinical pharmacy practice, enabling them to be competitive in the national and international workforce and capable of facing challenges in global market competition.
2. 2 To produce graduates who can implement pharmaceutical care and advance scientific knowledge based on clinical research, fostering comprehensive understanding and critical thinking in the fields of Biomedical Sciences and Clinical Pharmacy.
3. 3 To produce graduates who fulfill their professional responsibilities to society, integrating theoretical mastery, research outcomes, and practical experience to apply the principles of rational drug use in pharmaceutical care.
4. 4 To produce graduates who can implement real-world programs relevant to community needs and solve related problems, working effectively within healthcare teams and with related institutions.

Master’s Program in Clinical Pharmacy Identity:

Study Program Name Department Faculty University	: Master of Clinical Pharmacy : Clinical Pharmacy : Pharmacy : Universitas Airlangga
Address, phone number, fax, e-mail	: Campus C UNAIR,    Jl. Mulyorejo, Surabaya 60115    Phone (031) 5933150 Fax (031) 5935249   Email :      info@ff.unair.ac.id     mfk@ff.unair.ac.id
Accreditation	: Excellent (Unggul)   LAM-PTKes Decree No. : SK LAM-PTKes No. 0468/LAM-PTKes/Akr/Mag/V/2024   Valid : July 12, 2024 - July 11, 2029
Study Program Establishment Decree	: Rector Decree of Unair No. 615/H3/KR/2010
Document Issue Date	: April 28, 2010
Operational License Extension Decree	: Rector Decree No. 35/UN3/2018 dated January 4, 2018   Validity Period   January 16, 2018 - January 16, 2021